In 2023, Bruce Culleton, MD earned $366.68K in total compensation at ProKidney Corp., including $244.96K salary and $120.82K bonus. 2+ years at the helm of ProKidney Corp..
Compensation History
Annual executive compensation data for Bruce Culleton, MD, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$366.68K
Salary
$244.96K
Bonus
$120.82K
Other
$891.00
Salary
$244.96KBoard Justification
The compensation program is designed to attract, retain, and motivate senior management leaders capable of advancing the company's mission and strategy, rewarding them in alignment with financial performance and equity ownership.
Bonus
$120.82KBoard Justification
Cash bonuses earned by the named executive officers pursuant to our Non-Equity Incentive Compensation Plan for performance, with a corporate goal achievement of 59.8%.
Other Compensation
$891.00Board Justification
Represents all other compensation paid to Dr. Culleton including insurance premiums with respect to a group life insurance policy, a group short-term disability policy, a group long-term disability policy, an accidental death and dismemberment policy, and flexible spending accounts.
Restricted Stock
Board Justification
No stock awards vested in 2023 as per the provided data.
Performance Metrics
Performance metrics for the CEO's compensation in 2023 were based on corporate goal achievements.
Bruce Culleton, MD
CEO of ProKidney Corp.
Education
Bachelor's degree in Medical Science and a Doctor of Medicine degree from Memorial University of Newfoundland; MBA from Northwestern University, Kellogg School of Management.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1967 - 58 years ago
CEO of ProKidney Corp. for
2 years 0 months (Nov 2023 - Present)
Previous Experience
Vice President and General Manager of CVS Kidney Care, LLC; Vice President and Chief Medical Officer at CVS Kidney Care; Vice President, Global Clinical Development at Becton, Dickinson and Company; Vice President, Renal Therapeutic Area at Baxter International Inc.
Other ProKidney Corp. CEOs
Holdings
Track Bruce Culleton, MD's stock holdings and portfolio value over time.
Insider Trading
Bruce Culleton, MD's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Bruce Culleton, MD with competitor CEOs and industry peers.